Doctor of Medicine

He specializes in the treatment of neurosurgical brain tumors and craniocerebral trauma. He has undertaken a basic research (free exploration) project of Shenzhen Science and Technology Innovation Committee: Study on the Molecular Mechanism of How Dihydroartemisinin Inhibits the Epithelial-Mesenchymal Transition of U87 and U251 Glioma Cells (No. JCYJ20180307155043326).